Next week HCS Pharma will be present both at Forum Labo Paris (26th-28th March ) and at SCMC congress in Lille (28-29th March)! In Forum Labo we will have our own stand in the Lab’StartUp Village (stand G11), thanks to the organizers for selecting BIOMIMESYS® Brain for the fair! We Read more…
Victoria has joined us for a six-month internship in collaboration with the University of Technology of Compiègne. She will develop a liver biochip, using the BIOMIMESYS® Liver hydroscaffold. Victoria obtained her bachelor’s degree in Cellular Biology and Physiology. Currently she is finishing the 2nd year of Master’s Degree in Biotechnologies Read more…
Skin commensals are crucial in the maintenance of the epithelial barrier function, regulation of the host immune system, and prevent invasion of other pathogenic microbes. In this article, published in September 2018, Burmeister et al show that Staphlylococcus, Streptococcus, Pseudomonas, Corynebacterium, and anaerobes have both beneficial and harmful effects depending Read more…
The neurovasculaire unit (NVU) is composed of brain microvascular endothelial cells (BMECs) that form the Blood-Brain-Barrier (BBB), pericytes, neurons and glial cells. It regulates substance transport between blood and brain. BBB and NVU dysfonctions are associated with numerous neurological pathologies. Animal models are traditionally used in medical research but the Read more…
The first version of BIOMIMESYS Brain allows to form neurospheres. We now developped a new version of BIOMIMESYS Brain, which allows to form neuronal networks. This version have a higher porosity than BIOMIMESYS Brain (Neurosphere), that allows to better disperse the cells and thus to form cell network instead of Read more…
After a bachelor of science in biology, Solenne has been graduated with a two-year diploma “DUT Génie Biologique”, specialized in biological and biochemistry analysis. Afterwards, she wenty on with a professional bachelor’s degree dealing with the development of cosmetic and health products at Université Bretagne Sud in Vannes, where she Read more…
Jean-Baptise obtained his Master’s degree in Cellular and Molecular Biology at Paris-Sorbonne University in 2018 after a six-month internship with us. He focused on the development of a human microbiota model in collaboration with the Pharmacology Lab of University of Rennes 1 (INSERM U1230). He will keep on working on Read more…
Our CEO, Nathalie is the Chairwoman of the session “ Next Generation High-Content Bioimaging – Phenotypic Discovery” (Track 3 – session 2) at next SLAS Barcelona event. This event will bring together more than 1,000 scientists and technologists from around the world. The theme for the 2019 Europe Conference is Read more…
BIOMIMESYS® Oncology is mostly composed of hyaluronic acid (HA), biofunctionnalized with undenaturated collagen I. HA, by interacting with its binding proteins (CD44, RHAMM, ICAM-1), is an active participant in inflammatory, angiogenic, fibrotic and cancer-promoting processes (Figure 1). We are currently looking at the effect of different elastic moduli of BIOMIMESYS® Read more…
We were really happy to participate in SLAS2019 in Washington last week. In addition to spending a few relaxing days in Washington, we enjoyed the warm welcome of the US team of Molecular Devices. We had the opportunity to present HAPIx, our HCS robotic platform fully designed and integrated by Read more…
HCS Pharma is one of the winner of the Lab’StartUp village, organized by Forum Labo! As such, we have won a stand in the heart of the forum (March 26-28, 2019)… Thanks a lot to the committee for evaluating our application to this prize, and for selecting our new product Read more…
Extracellular matrix (ECM) is known to have an influence on physiological processes and on tumour progression: ECM properties (composition, stiffness) modulate cell proliferation, migration, invasion and epithelial-to-mesenchymal transition (EMT). For example, EMT is inhibited by laminin-rich environment whereas it is promoted in fibronectin-rich ECM (Chen et al 2013. Differentiation 86, Read more…
Most potential drug candidates (90%) fail within the clinical trials, mainly because of lack of efficacy. What if the pharmaceutical industry uses predictive human in vitro models in early drug discovery ? View and download on Slideshare (low quality) https://fr.slideshare.net/hcspharma/a-groundbreaking-3d-cell-culture-technology-for-hcs-biomimesys-hydroscaffold Ask for high quality link by putting your email below
Last week we attend the 19th “Journées Européenes de Dermocosmetologie”. This year symposium was about “Intercellular exchanges in cutaneous tissues: which prospects in dermocosmetology for fragile skins ?” and we were very impressed by the top tier works we have seen there! We have met academics and industrials who are Read more…
Many news have been published since 2 or 3 years about Artificial Intelligence (AI) and Machine Learning / Deep Learning use in picture analysis. Lastly, Microsoft published an astonishing article where they explained that this technology is so powerful that the government needs to regulate it, especially for face recognition. Read more…
A new BIOMIMESYS® hydroscaffold is available for 3D cell culture! This hydroscaffold is suitable for neuronal cell culture. We tested it for two cell lines: SH-SY5Y cells, commonly used for pharmaceutical research, and LUHMES cells (dopaminergic neurons). Cells grow and form spheroids with intra and inter-spheroidal neurites. BIOMIMESYS® hydroscaffold allows Read more…
We will be at the next edition of SLAS meeting in Washington, DC February 2nd and 3th. If you wish to meet us, we will welcome you on our partner’s booth, Molecular Devices (#437) We will talk about “Phenotypic screening in 3D culture including ECM: advantages and challenges” on Monday, Read more…
Large number of visitors came to Cosmet’agora last week to discover the last innovations in cosmetic formulation. It was a great opportunity to discuss with leader companies developing active ingredients and to feel emerging trends in the cosmetic market: microbiota balance preservation and chronobiology in particular. Our fully automatic wound Read more…
Every year, the CES (Consumer Electronics Show) in Las Vegas is the major meeting for technological innovations for consumer market. This year, many companies (more than 600) presented products and services in the healthcare domain (including medtech and wellness). It represents a 25% increase compared to 2018. Why is this Read more…
The European Center of Dermocosmetology is a french professional association dedicated to the promotion of a high level of education in cosmetology and dermatology. This year, the “Journées Européenes de Dermocosmétologie” will focus on the “intercellular dialogue in the cutaneous tissue: what perspectives in dermocosmetology targeted on weakened skins?” We Read more…
Review of Human neuro-astrocytes 3D co-culture-based assay for evaluation of neuroprotective compounds (Terrasso et al. 2017) Terrasso et al. published a study about a neuroprotection assay on a 3D model in 2017. They developed a 3D co-culture of neurons and astrocytes by means of an agitation-based culture system. Then they Read more…
Cosmetagora is organized by the “Société Française de Cosmetologie” and is one of the major french event in terms of cosmetic formulation. Our study director Pierre-Jean and our business developer Nathalie Accornero will be present during the two days of the event.
We are very happy to wish you a wonderful year 2019!
Nous sommes très heureux de vous souhaiter une excellente année 2019 !